TIMP2 and cancer: Therefore, high expression of miR-130b may affect the overall survival of patients with NSCLC by targeting TIMP-2, which in turn promotes cancer cell invasion and enhances the functions of endothelial cells and myeloid-derived suppressor cells in tumor tissues.